| 1 |
Cleveland HH, Knapp KS, Cleveland MJ, Deneke E, Bunce SC. Using ecological momentary assessments of negative affect and craving during residential opioid use disorder treatment to predict patients' relapse to substance use. J Subst Use Addict Treat 2023;146:208931. [PMID: 36880896 DOI: 10.1016/j.josat.2022.208931] [Reference Citation Analysis]
|
| 2 |
Leventelis C, Katsouli A, Stavropoulos V, Karasavvidou A, Papadopoulos P, Barmpas PT, Tasoulis S, Veskoukis AS, Tsironi M. The development and validation of the pandemic medication-assisted treatment questionnaire for the assessment of pandemic crises impact on medication management and administration for patients with opioid use disorders. Nordisk Alkohol Nark 2023;40:76-94. [PMID: 36793483 DOI: 10.1177/14550725221135574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Taubin D, Berger A, Greenwald D, Greenwald H, Burke C, Gongora DS, Wilens T. A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes. Am J Addict 2023;32:13-23. [PMID: 36128667 DOI: 10.1111/ajad.13342] [Reference Citation Analysis]
|
| 4 |
Smit T, Mayorga NA, Rogers AH, Woods SP, Heggeness LF, Kauffman BY, Garey L, Zvolensky MJ. Indirect Effects of Negative Mood on Opioid Misuse and Dependence via Anxiety Sensitivity Subfacets: Evidence from Adults Reporting Chronic Pain. Subst Use Misuse 2023;58:570-7. [PMID: 36762460 DOI: 10.1080/10826084.2023.2177969] [Reference Citation Analysis]
|
| 5 |
Mantsch JR. Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations. Addict Neurosci 2022;4:100038. [PMID: 36531188 DOI: 10.1016/j.addicn.2022.100038] [Reference Citation Analysis]
|
| 6 |
Testa A, Crawford AD, Jackson DB, Gemmill A. Stressful life events and prescription opioid use during pregnancy: findings from the 2019 pregnancy risk assessment monitoring system. Soc Psychiatry Psychiatr Epidemiol 2022;57:2181-91. [PMID: 35947167 DOI: 10.1007/s00127-022-02349-0] [Reference Citation Analysis]
|
| 7 |
McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Foll BL, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial. Drug Alcohol Depend 2022;239:109604. [PMID: 36037586 DOI: 10.1016/j.drugalcdep.2022.109604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Votaw VR, Tuchman FR, Piccirillo ML, Schwebel FJ, Witkiewitz K. Examining Associations Between Negative Affect and Substance Use in Treatment-Seeking Samples: a Review of Studies Using Intensive Longitudinal Methods. Curr Addict Rep. [DOI: 10.1007/s40429-022-00441-8] [Reference Citation Analysis]
|
| 9 |
Petrie DJ, Knapp KS, Freet CS, Deneke E, Brick TR, Cleveland HH, Bunce SC. Prefrontal cortical response to natural rewards and self-reported anhedonia are associated with greater craving among recently withdrawn patients in residential treatment for opioid use disorder. Brain Res Bull 2022;190:32-41. [PMID: 36122801 DOI: 10.1016/j.brainresbull.2022.09.012] [Reference Citation Analysis]
|
| 10 |
Ellis JD, Mun CJ, Epstein DH, Phillips KA, Finan PH, Preston KL. Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder. Neuropsychopharmacology 2022;47:1836-43. [PMID: 35668168 DOI: 10.1038/s41386-022-01352-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Chiang S, Knapp KS, Bai S, Cleveland HH, Harris KS. Examining within- and between-person facets of negative affect and associations with daily craving among young adults in substance use disorder recovery. Addiction Research & Theory. [DOI: 10.1080/16066359.2022.2102611] [Reference Citation Analysis]
|
| 12 |
Pribic MR, Black AH, Beale AD, Gauvin JA, Chiang LN, Rose JK. Association of Two Opposing Responses Results in the Emergence of a Novel Conditioned Response. Front Behav Neurosci 2022;16:852266. [DOI: 10.3389/fnbeh.2022.852266] [Reference Citation Analysis]
|
| 13 |
Burgess-Hull AJ, Panlilio LV, Preston KL, Epstein DH. Trajectories of craving during medication-assisted treatment for opioid-use disorder: Subtyping for early identification of higher risk. Drug Alcohol Depend 2022;233:109362. [PMID: 35217274 DOI: 10.1016/j.drugalcdep.2022.109362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Marsch LA, Chen CH, Adams SR, Asyyed A, Does MB, Hassanpour S, Hichborn E, Jackson-Morris M, Jacobson NC, Jones HK, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, Subramaniam G, Wu W, Campbell CI. The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations. Front Psychiatry 2022;13:871916. [PMID: 35573377 DOI: 10.3389/fpsyt.2022.871916] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Ellis JD, Mayo JL, Finan PH, Gamaldo CE, Huhn AS. Clinical correlates of drug-related dreams in opioid use disorder. Am J Addict 2022;31:37-45. [PMID: 34459058 DOI: 10.1111/ajad.13219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Price JL, Bates ME, Pawlak AP, Uhouse SG, Todaro SM, Morgano J, Buckman JF. Use and perceived usefulness of a just-in-time resonance breathing intervention adjunct for substance use disorder: Contextual and physiological predictors. Front Psychiatry 2022;13:945751. [PMID: 36159943 DOI: 10.3389/fpsyt.2022.945751] [Reference Citation Analysis]
|
| 17 |
Finan PH, Letzen J, Epstein DH, Mun CJ, Stull S, Kowalczyk WJ, Agage D, Phillips KA, Pizzagalli DA, Preston KL. Reward Responsiveness in Patients with Opioid Use Disorder on Opioid Agonist Treatment: Role of Comorbid Chronic Pain. Pain Med 2021;22:2019-27. [PMID: 33624802 DOI: 10.1093/pm/pnab031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Burgess-Hull AJ, Smith KE, Schriefer D, Panlilio LV, Epstein DH, Preston KL. Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients. Drug Alcohol Depend 2021;226:108884. [PMID: 34229153 DOI: 10.1016/j.drugalcdep.2021.108884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Saraiya TC, Jarnecke AM, Jones J, Brown DG, Brady KT, Back SE. Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder. Drug Alcohol Depend 2021;225:108755. [PMID: 34052686 DOI: 10.1016/j.drugalcdep.2021.108755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Mun CJ, Finan PH, Epstein DH, Kowalczyk WJ, Agage D, Letzen JE, Phillips KA, Preston KL. Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid-use disorder: an ecological momentary assessment study. Addiction 2021;116:1794-804. [PMID: 33220102 DOI: 10.1111/add.15344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Panlilio LV, Stull SW, Bertz JW, Burgess-Hull AJ, Lanza ST, Curtis BL, Phillips KA, Epstein DH, Preston KL. Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use. Psychopharmacology (Berl) 2021;238:1513-29. [PMID: 33558983 DOI: 10.1007/s00213-021-05782-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 22 |
Bergeria CL, Strickland JC, Huhn AS, Strain EC, Dunn KE. A preliminary examination of the multiple dimensions of opioid craving. Drug Alcohol Depend 2021;219:108473. [PMID: 33429294 DOI: 10.1016/j.drugalcdep.2020.108473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 23 |
Jenkins GJ, Cleveland MJ, Knapp KS, Bunce SC, Cleveland HH. Examining the time-varying association of negative affect and covariates with craving during treatment for prescription opioid dependence with two types of mixed models. Addict Behav 2021;113:106674. [PMID: 33049429 DOI: 10.1016/j.addbeh.2020.106674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Burgess-Hull A, Epstein DH. Ambulatory Assessment Methods to Examine Momentary State-Based Predictors of Opioid Use Behaviors. Curr Addict Rep 2021;:1-14. [PMID: 33425652 DOI: 10.1007/s40429-020-00351-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Marsch LA. Digital health data-driven approaches to understand human behavior. Neuropsychopharmacology 2021;46:191-6. [PMID: 32653896 DOI: 10.1038/s41386-020-0761-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 26 |
Fuchs-Leitner I, Yazdi K, Gerstgrasser NW, Tholen MG, Graffius ST, Schorb A, Rosenleitner J. Risk of PTSD Due to the COVID-19 Pandemic Among Patients in Opioid Substitution Treatment. Front Psychiatry 2021;12:729460. [PMID: 34658964 DOI: 10.3389/fpsyt.2021.729460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Rogers JM, Epstein DH, Phillips K, Strickland JC, Preston KL. Exploring the Relationship Between Substance Use and Allostatic Load in a Treatment/Research Cohort and in a US Probability Sample (NHANES 2009-2016). Front Psychiatry 2021;12:630195. [PMID: 34408672 DOI: 10.3389/fpsyt.2021.630195] [Reference Citation Analysis]
|
| 28 |
Knapp KS, Bunce SC, Brick TR, Deneke E, Cleveland HH. Daily associations among craving, affect, and social interactions in the lives of patients during residential opioid use disorder treatment. Psychol Addict Behav 2021;35:609-20. [PMID: 33090811 DOI: 10.1037/adb0000612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Egervari G, Akpoyibo D, Rahman T, Fullard JF, Callens JE, Landry JA, Ly A, Zhou X, Warren N, Hauberg ME, Hoffman G, Ellis R, Ferland JN, Miller ML, Keller E, Zhang B, Roussos P, Hurd YL. Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder. Nat Commun 2020;11:4634. [PMID: 32929078 DOI: 10.1038/s41467-020-18114-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 30 |
Marsch LA. Digital Health and Addiction. Curr Opin Syst Biol 2020;20:1-7. [PMID: 32885099 DOI: 10.1016/j.coisb.2020.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 31 |
Williams JR, Cole V, Girdler S, Cromeens MG. Exploring stress, cognitive, and affective mechanisms of the relationship between interpersonal trauma and opioid misuse. PLoS One 2020;15:e0233185. [PMID: 32413081 DOI: 10.1371/journal.pone.0233185] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 32 |
Epstein DH, Tyburski M, Kowalczyk WJ, Burgess-Hull AJ, Phillips KA, Curtis BL, Preston KL. Prediction of stress and drug craving ninety minutes in the future with passively collected GPS data. NPJ Digit Med 2020;3:26. [PMID: 32195362 DOI: 10.1038/s41746-020-0234-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 33 |
Fronk GE, Sant'Ana SJ, Kaye JT, Curtin JJ. Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research. Annu Rev Clin Psychol 2020;16:401-30. [PMID: 32040338 DOI: 10.1146/annurev-clinpsy-102419-125016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Carpenter RW, Lane SP, Bruehl S, Trull TJ. Concurrent and lagged associations of prescription opioid use with pain and negative affect in the daily lives of chronic pain patients. J Consult Clin Psychol 2019;87:872-86. [PMID: 31556664 DOI: 10.1037/ccp0000402] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, Preston KL, Ramey T, Smith SM, Turk DC, Walsh R, Weiss RD, Strain EC. Craving and opioid use disorder: A scoping review. Drug Alcohol Depend 2019;205:107639. [PMID: 31683241 DOI: 10.1016/j.drugalcdep.2019.107639] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 36 |
Ling W, Shoptaw S, Goodman-Meza D. Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation. Subst Abuse Rehabil 2019;10:69-78. [PMID: 31819701 DOI: 10.2147/SAR.S155843] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 37 |
Wemm SE, Larkin C, Hermes G, Tennen H, Sinha R. A day-by-day prospective analysis of stress, craving and risk of next day alcohol intake during alcohol use disorder treatment. Drug Alcohol Depend 2019;204:107569. [PMID: 31574406 DOI: 10.1016/j.drugalcdep.2019.107569] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 38 |
Panlilio LV, Stull SW, Kowalczyk WJ, Phillips KA, Schroeder JR, Bertz JW, Vahabzadeh M, Lin JL, Mezghanni M, Nunes EV, Epstein DH, Preston KL. Stress, craving and mood as predictors of early dropout from opioid agonist therapy. Drug Alcohol Depend 2019;202:200-8. [PMID: 31357121 DOI: 10.1016/j.drugalcdep.2019.05.026] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 39 |
Kakko J, Alho H, Baldacchino A, Molina R, Nava FA, Shaya G. Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. Front Psychiatry 2019;10:592. [PMID: 31543832 DOI: 10.3389/fpsyt.2019.00592] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
|
